Clinical Trial Update: An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1 [Phase 1]

View source ↗

Summary

An extension Phase 1 study update evaluating the long-term equivalence of CT-P13 with infliximab (Remicade) in patients with Ankylosing Spondylitis to assess su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• CT-P13 (infliximab biosimilar)
• Remicade (infliximab)

Snippet

Sponsor: Celltrion | Conditions: Ankylosing Spondylitis | Phase 1 | Status: COMPLETED